- Home
- TTNP vs HSCS Comparison
TTNP vs HSCS Comparison
Compare TTNP & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- HSCS
- Stock Information
- Founded
- TTNP 1991
- HSCS 2007
- Country
- TTNP United States
- HSCS United States
- Employees
- TTNP N/A
- HSCS N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- HSCS Medical Specialities
- Sector
- TTNP Health Care
- HSCS Health Care
- Exchange
- TTNP Nasdaq
- HSCS Nasdaq
- Market Cap
- TTNP 3.4M
- HSCS 2.8M
- IPO Year
- TTNP 1996
- HSCS 2022
- Fundamental
- Price
- TTNP $4.00
- HSCS $2.80
- Analyst Decision
- TTNP
- HSCS Strong Buy
- Analyst Count
- TTNP 0
- HSCS 2
- Target Price
- TTNP N/A
- HSCS $13.00
- AVG Volume (30 Days)
- TTNP 33.6K
- HSCS 13.0K
- Earning Date
- TTNP 05-14-2025
- HSCS 03-13-2025
- Dividend Yield
- TTNP N/A
- HSCS N/A
- EPS Growth
- TTNP N/A
- HSCS N/A
- EPS
- TTNP N/A
- HSCS N/A
- Revenue
- TTNP N/A
- HSCS N/A
- Revenue This Year
- TTNP N/A
- HSCS N/A
- Revenue Next Year
- TTNP N/A
- HSCS N/A
- P/E Ratio
- TTNP N/A
- HSCS N/A
- Revenue Growth
- TTNP N/A
- HSCS 261.17
- 52 Week Low
- TTNP $3.03
- HSCS $2.36
- 52 Week High
- TTNP $14.80
- HSCS $13.50
- Technical
- Relative Strength Index (RSI)
- TTNP 55.27
- HSCS 40.13
- Support Level
- TTNP $3.48
- HSCS $2.75
- Resistance Level
- TTNP $4.47
- HSCS $2.95
- Average True Range (ATR)
- TTNP 0.35
- HSCS 0.15
- MACD
- TTNP 0.01
- HSCS 0.00
- Stochastic Oscillator
- TTNP 56.07
- HSCS 11.90
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.